Page 121 - 南京医科大学学报自然科学版
P. 121

第43卷第8期       张梦怡,冯孟文,张 倩,等. 头孢他啶阿维巴坦治疗碳青霉烯类耐药铜绿假单胞菌感染的疗效与
                  2023年8月              安全性分析[J]. 南京医科大学学报(自然科学版),2023,43(8):1150-1155                   ·1155 ·


                    world experience with ceftazidime⁃avibactam for multidrug  [19] VARDAKAS K Z,MAVROUDIS A D,GEORGIOU M,et
                    ⁃resistant gram⁃negative bacterial infections[J]. Open Fo⁃  al. Intravenous plus inhaled versus intravenous colistin
                    rum Infect Dis,2019,6(12):z522                     monotherapy for lower respiratory tract infections:a sys⁃
               [16] BONINE N G,BERGER A,ALTINCATAL A,et al. Im⁃        tematic review and meta⁃analysis[J]. J Infect,2018,76
                    pact of delayed appropriate antibiotic therapy on patient  (4):321-327
                    outcomes by antibiotic resistance status from serious gram⁃  [20] ABDELLATIF S,TRIFI A,DALY F,et al. Efficacy and
                    negative bacterial infections[J]. Am J Med Sci,2019,357  toxicity of aerosolised colistin in ventilator ⁃ associated
                    (2):103-110                                        pneumonia:a prospective,randomised trial[J]. Ann In⁃
               [17] STRICH J R,RICOTTA E,WARNER S,et al. Pharmaco⁃     tensive Care,2016,6(1):26
                    epidemiology of Ceftazidime⁃avibactam use:a retrospec⁃  [21] SATLIN M J. Languid Uptake of ceftazidime ⁃ avibactam
                    tive cohort analysis of 210 US hospitals[J]. Clin Infect  for carbapenem ⁃ resistant gram ⁃ negative infections and
                    Dis,2021,72(4):611-621                             continued reliance on polymyxins[J]. Clin Infect Dis,
               [18] TSUJI B T,POGUE J M,ZAVASCKI A P,et al. Interna⁃   2021,72(4):622-625
                    tional consensus guidelines for the optimal use of the poly⁃  [22] STERNBACH N,LEIBOVICI W Y,AVNI T,et al. Effica⁃
                    myxins:endorsed by the American College of Clinical  cy and safety of ceftazidime/avibactam:a systematic re⁃
                    Pharmacy(ACCP),European Society of Clinical Microbi⁃  view and meta ⁃ analysis[J]. J Antimicrob Chemother,
                    ology and Infectious Diseases(ESCMID),Infectious Dis⁃  2018,73(8):2021-2029
                    eases Society of America(IDSA),International Society  [23] 刘晓东,张盼盼,于  丹,等. 头孢他啶⁃阿维巴坦药物
                    for Anti⁃infective Pharmacology(ISAP),Society of Criti⁃  不良反应的文献分析[J]. 中国临床药理学杂志,2020,
                    cal Care Medicine(SCCM),and Society of Infectious Dis⁃  36(16):2504-2506
                    eases Pharmacists(SIDP)[J]. Pharmacotherapy,2019,39                     [收稿日期] 2023-05-09
                    (1):10-39                                                                   (本文编辑:唐      震)






                






               (上接第1149页)                                        [11] MADOKA F,KAORI H,YUKA K,Point⁃of⁃care ultra⁃
                    functional nanoplatform for visual chemo ⁃ hyperthermia  sound in the head and neck region[J]. J Med Ultrason,
                    synergy therapy on metastatic lymph nodes via lymphatic  2022,49(4):593-600
                    delivery[J]. J Nanobiotechnology,2021,19(1):432-  [12] ZAKE T,KALERE I,UPMALE⁃ENGELA S,et al. Plas⁃
                    450                                                ma levels of Th17⁃associated cytokines and selenium sta⁃
               [10] ABBAS A,SAMAN S,SEYED M M Y,et al. The inci⁃       tus in autoimmune thyroid diseases[J]. Immuninflamm
                    dence and features of delphian lymph node involvement  Dis,20219(3):792-803
                    in patients with papillary thyroid carcinoma[J]. BMC                    [收稿日期] 2023-02-19
                    Surg,2022,22(1):320-325                                                     (本文编辑:唐      震)
   116   117   118   119   120   121   122   123   124   125   126